Cargando…
Canadian Physicians' Use of Antiobesity Drugs and Their Referral Patterns to Weight Management Programs or Providers: The SOCCER Study
Antiobesity pharmacotherapy and programs/providers that possess weight management expertise are not commonly used by physicians. The underlying reasons for this are not known. We performed a cross-sectional study in 33 Canadian medical practices (36 physicians) examining 1788 overweight/obese adult...
Autores principales: | Padwal, R. S., Damjanovic, S., Schulze, K. M., Lewanczuk, R. Z., Lau, D. C. W., Sharma, A. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989451/ https://www.ncbi.nlm.nih.gov/pubmed/21113310 http://dx.doi.org/10.1155/2011/686521 |
Ejemplares similares
-
Predictors of weight loss and maintenance in patients treated with antiobesity drugs
por: Guaraldi, Federica, et al.
Publicado: (2011) -
An Automated Internet Behavioral Weight-Loss Program by Physician Referral: A Randomized Controlled Trial
por: Thomas, J. Graham, et al.
Publicado: (2015) -
An Updated Approach to Antiobesity Pharmacotherapy: Moving Beyond the 5% Weight Loss Goal
por: Enright, Connor, et al.
Publicado: (2023) -
Lorcaserin: A novel antiobesity drug
por: Brashier, Dick B. S., et al.
Publicado: (2014) -
Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity: A Randomized Clinical Trial
por: Pantalone, Kevin M., et al.
Publicado: (2021)